Canon Inc-spons adr, 3Q operating profit increased by 14.4% to 296.6 billion yen.

Canon Inc-spons adr <7751> announced its third quarter financial results for the fiscal year ending December 2024, with revenue increasing by 7.3% year-on-year to 3 trillion 236.1 billion 11 million yen, and operating profit increasing by 14.4% to 296.6 billion 38 million yen. The gross profit margin increased to 47.8%, surpassing the same period last year by 0.8 points, due to cost reductions and improvements in product mix, with gross profit also increasing by 7.1% year-on-year to 516.4 billion yen. Positive evaluation for Takeda Pharmaceutical Co., Ltd. <4502> in the mid-term and Sony Corporation <7735>.

Fisco JapanNov 1 05:22

Shima Seiki Mfg: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (Consolidated)

JPXOct 31 14:10 · Announcements

Shima Seiki Mfg 1H Loss Y2.12B Vs Net Y368.00M

Dow JonesOct 31 14:10

Daiichi Sankyo, Fujitsu, JR East Japan, ANA (31st)

※The above calendar is subject to change depending on the company's schedule.---------------------------------------October 31st (Thursday) ＜1777＞Kawasaki Facilities ＜1798＞Morita Shokai ＜1911＞Sumitomo-Rin ＜1934＞Yuatec ＜1939＞Yondenko ＜1941＞Chudenko ＜1942＞Kandenko ＜1944＞Kinden ＜194

Fisco JapanOct 31 05:30

Shima Seiki Mfg To Go Ex-Dividend On September 27th, 2024 With 5 JPY Dividend Per Share

September 26th (Japan Standard Time) - $Shima Seiki Mfg(6222.JP)$ is trading ex-dividend on September 27th, 2024.Shareholders of record on September 30th, 2024 will receive 5 JPY dividend per share.

Futu NewsSep 26 09:00

Stocks moved the previous day part1: Celes, Nippon Steel, Sakura Internet, etc.

Stock Name Closing Price on the 24th ⇒ Day-to-Day Comparison Aizawa Securities <8708> 1844 +3325. The interim dividends for the fiscal year ending in March are scheduled to be 13 yen for regular dividends and 35 yen for special dividends, totaling 48 yen. Kyosan Electric <6742> 496 -1425 revised downward the performance financial estimates for the first half of the fiscal year ending in March. Progress in joint drug discovery research with Otsuka Pharmaceutical <4507> led to milestone achievement. Grandees <3261> 634 +100 established a shareholder benefits program. Progress in joint drug discovery research with Otsuka Pharmaceutical <4507> led to milestone achievement. Grandees <3261> 634 +100 established a shareholder benefits program. QPS Research Institute <55>

Fisco JapanSep 25 06:15